Form 4: Encompass Health Director Acquires Additional Shares Through Deferred Stock Plan

Director Christopher R. Reidy acquired 360 shares of Encompass Health Corp through the company's deferred stock investment plan at a weighted average price of $98.23 on April 22, 2025.

Summary

• On April 22, 2025, Christopher R. Reidy, a director of Encompass Health Corp, acquired 360 shares of the company's common stock.
• The acquisition was made through the Directors Deferred Stock Investment Plan.
• The weighted average price for the shares was $98.23.
• Following the transaction, Reidy directly owns 13,007 shares of Encompass Health common stock.
• The shares were purchased in multiple transactions at prices ranging from $98.23 to $98.24.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a director increasing their stake in the company, which is generally seen as a sign of confidence. However, it's a routine transaction under a pre-existing plan.

Positives

• The director's participation in the deferred stock investment plan demonstrates confidence in the company's future.

Industry Context

Directors commonly use deferred stock plans as part of their overall compensation and wealth management strategy, aligning their interests with those of shareholders.

Stakeholder Impact

• The transaction has a minor positive impact on shareholder confidence as it shows a director's continued investment in the company.

Key Dates

Keywords

Encompass Health, Director, Stock Acquisition, Deferred Stock Plan, EHC, Insider Trading, Form 4